View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Executing a Successful Remediation Programme Webinar by NSF

Join our webinar on Tuesday 10 December at 3PM London / 10AM New York to find out how a strategic and well planned-out remediation effort is principal to long-term maintainable corrections.

Furthermore, you can gain insight on how NSF uniquely views the process, executing using our industry experience to ensure that when new systems are put in place, they will address overlooked aspects of remediation, the underlying causes and the support systems that drive actual sustainable change and provide fundamental success factors.

Jesse Ahrendt will be presenting the webinar. Ahrendt is an experienced industry consultant with over 20 years of active engagement in pharmaceuticals, medical devices and biotechnology as a certified Quality Auditor and Quality Engineer.

His areas of expertise include QA Compliance, third-party vendor evaluation, cGMP manufacturing, quality systems and quality auditing including CAPA, Investigations, validation, mock inspection, supplier qualification, QMS, risk assessment and procedural updates.

NSF provides a comprehensive range of pharmaceutical support services, including consulting, auditing, training and regulatory compliance, helping clients to address industry challenges and public health and safety concerns, as well as meet the stringent requirements of the pharmaceutical industry.

For more information on how to sign up to the webinar, please fill out the enquiry form attached to this page.

NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology